Cholesterol lowering drug combination

Details for Australian Patent Application No. 2007284958 (hide)

Owner Duke University

Inventors Stamler, Jonathan S.

Agent Davies Collison Cave

Pub. Number AU-A-2007284958

PCT Pub. Number WO2008/020962

Priority 60/835,912 07.08.06 US; 11/812,399 19.06.07 US

Filing date 24 July 2007

Wipo publication date 21 February 2008

International Classifications

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

Event Publications

26 March 2009 PCT application entered the National Phase

  PCT publication WO2008/020962 Priority application(s): WO2008/020962

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007284964-Recombinant interferon-beta with enhanced biological activity

2007284956-Hybrid promoters